AB

Ashok Bhagwatrao Solanke

Active Director Director DIN 08338004
DIN 08338004 First appointment Jan 2019 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Ashok Bhagwatrao Solanke

Data last updated:

Ashok Bhagwatrao Solanke is a Director at Igms Healthcare Private Limited (since 2019). The company operates in Pharma.

DIN 08338004
Primary Designation Director
Industry Pharma
First Appointment 21 Jan 2019
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Igms Healthcare Private Limited U51909MH2019PTC319944
Director21 Jan 20192019Active

Directorship timeline

Open interactive timeline →
Igms Healthcare Private Limited
Premium access

Shareholding and investment profile for Ashok Bhagwatrao Solanke

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashok Bhagwatrao Solanke

Ashok Bhagwatrao Solanke currently holds 1 directorship: Igms Healthcare Private Limited (Director, since 21 Jan 2019).

Ashok Bhagwatrao Solanke was first appointed on 21 Jan 2019 as Director at Igms Healthcare Private Limited.

The current boards of Ashok Bhagwatrao Solanke's companies include Atharwa Prashant Deodhe (Igms Healthcare Private Limited), Chndarashekhar Diliprao Barahatte (Igms Healthcare Private Limited), Gopal Bapurao Bochare (Igms Healthcare Private Limited), Keshav Bapurao Bochare (Igms Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available